These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 19417148

  • 41. Topoisomerase I-DNA complexes contribute to arsenic trioxide-induced apoptosis.
    Sordet O, Liao Z, Liu H, Antony S, Stevens EV, Kohlhagen G, Fu H, Pommier Y.
    J Biol Chem; 2004 Aug 06; 279(32):33968-75. PubMed ID: 15178684
    [Abstract] [Full Text] [Related]

  • 42. [Changes of gene expression profile of multiple myeloma cell line RPMI 8226 treated by arsenic trioxide].
    Wang MC, Liu SX, Liu PB.
    Zhong Xi Yi Jie He Xue Bao; 2006 Mar 06; 4(2):160-5. PubMed ID: 16529693
    [Abstract] [Full Text] [Related]

  • 43. Potentiation of arsenic trioxide cytotoxicity by Parthenolide and buthionine sulfoximine in murine and human leukemic cells.
    Duechler M, Stańczyk M, Czyz M, Stepnik M.
    Cancer Chemother Pharmacol; 2008 Apr 06; 61(5):727-37. PubMed ID: 17594095
    [Abstract] [Full Text] [Related]

  • 44. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines.
    Kito M, Akao Y, Ohishi N, Yagi K, Nozawa Y.
    Biochem Biophys Res Commun; 2002 Mar 08; 291(4):861-7. PubMed ID: 11866444
    [Abstract] [Full Text] [Related]

  • 45. Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6.
    Qu X, Du J, Zhang C, Fu W, Xi H, Zou J, Hou J.
    PLoS One; 2012 Mar 08; 7(2):e32215. PubMed ID: 22384180
    [Abstract] [Full Text] [Related]

  • 46. Arsenic trioxide induces multiple myeloma cell apoptosis via disruption of mitochondrial transmembrane potentials and activation of caspase-3.
    Jia P, Chen G, Huang X, Cai X, Yang J, Wang L, Zhou Y, Shen Y, Zhou L, Yu Y, Chen S, Zhang X, Wang Z.
    Chin Med J (Engl); 2001 Jan 08; 114(1):19-24. PubMed ID: 11779429
    [Abstract] [Full Text] [Related]

  • 47. Arsenic trioxide downregulates specificity protein (Sp) transcription factors and inhibits bladder cancer cell and tumor growth.
    Jutooru I, Chadalapaka G, Sreevalsan S, Lei P, Barhoumi R, Burghardt R, Safe S.
    Exp Cell Res; 2010 Aug 01; 316(13):2174-88. PubMed ID: 20435036
    [Abstract] [Full Text] [Related]

  • 48. Enhanced Bcr-Abl-specific antileukemic activity of arsenic trioxide (Trisenox) through glutathione-depletion in imatinib-resistant cells.
    Konig H, Härtel N, Schultheis B, Schatz M, Lorentz C, Melo JV, Hehlmann R, Hochhaus A, La Rosée P.
    Haematologica; 2007 Jun 01; 92(6):838-41. PubMed ID: 17550858
    [Abstract] [Full Text] [Related]

  • 49. Combination treatment with arsenic trioxide and phytosphingosine enhances apoptotic cell death in arsenic trioxide-resistant cancer cells.
    Park MT, Kang YH, Park IC, Kim CH, Lee YS, Chung HY, Lee SJ.
    Mol Cancer Ther; 2007 Jan 01; 6(1):82-92. PubMed ID: 17237268
    [Abstract] [Full Text] [Related]

  • 50. Resistance of human multidrug resistance-associated protein 1-overexpressing lung tumor cells to the anticancer drug arsenic trioxide.
    Vernhet L, Allain N, Payen L, Anger JP, Guillouzo A, Fardel O.
    Biochem Pharmacol; 2001 Jun 01; 61(11):1387-91. PubMed ID: 11331074
    [Abstract] [Full Text] [Related]

  • 51. [Mechanisms of arsenic trioxide-induced apoptosis in myeloma cells].
    Zhou Y, Huang X, Cai X.
    Zhonghua Zhong Liu Za Zhi; 2001 May 01; 23(3):181-3. PubMed ID: 11783079
    [Abstract] [Full Text] [Related]

  • 52. Arsenic trioxide and melarsoprol induce apoptosis in plasma cell lines and in plasma cells from myeloma patients.
    Rousselot P, Labaume S, Marolleau JP, Larghero J, Noguera MH, Brouet JC, Fermand JP.
    Cancer Res; 1999 Mar 01; 59(5):1041-8. PubMed ID: 10070961
    [Abstract] [Full Text] [Related]

  • 53. Potentiation of arsenic trioxide-induced apoptosis by 8-bromo-7-methoxychrysin in human leukemia cells involves depletion of intracellular reduced glutathione.
    Xiao G, Tang X, Yao C, Wang C.
    Acta Biochim Biophys Sin (Shanghai); 2011 Sep 01; 43(9):712-21. PubMed ID: 21785114
    [Abstract] [Full Text] [Related]

  • 54. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
    Cheng B, Yang X, An L, Gao B, Liu X.
    Auris Nasus Larynx; 2010 Feb 01; 37(1):89-94. PubMed ID: 19574005
    [Abstract] [Full Text] [Related]

  • 55. microRNA expression alteration after arsenic trioxide treatment in HepG-2 cells.
    Meng XZ, Zheng TS, Chen X, Wang JB, Zhang WH, Pan SH, Jiang HC, Liu LX.
    J Gastroenterol Hepatol; 2011 Jan 01; 26(1):186-93. PubMed ID: 21175813
    [Abstract] [Full Text] [Related]

  • 56. Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the antileukemic drug arsenic trioxide in human leukemia cell lines.
    Ramos AM, Aller P.
    Biochem Pharmacol; 2008 May 15; 75(10):1912-23. PubMed ID: 18359480
    [Abstract] [Full Text] [Related]

  • 57. RWJ-241947 (MCC-555), a unique peroxisome proliferator-activated receptor-gamma ligand with antitumor activity against human prostate cancer in vitro and in beige/nude/ X-linked immunodeficient mice and enhancement of apoptosis in myeloma cells induced by arsenic trioxide.
    Kumagai T, Ikezoe T, Gui D, O'Kelly J, Tong XJ, Cohen FJ, Said JW, Koeffler HP.
    Clin Cancer Res; 2004 Feb 15; 10(4):1508-20. PubMed ID: 14977855
    [Abstract] [Full Text] [Related]

  • 58. Arsenic trioxide induces apoptosis in cells of MOLT-4 and its daunorubicin-resistant cell line via depletion of intracellular glutathione, disruption of mitochondrial membrane potential and activation of caspase-3.
    Hu XM, Hirano T, Oka K.
    Cancer Chemother Pharmacol; 2003 Jul 15; 52(1):47-58. PubMed ID: 12750841
    [Abstract] [Full Text] [Related]

  • 59. Arsenic trioxide circumvents multidrug resistance based on different mechanisms in human leukemia cell lines.
    Seo T, Urasaki Y, Takemura H, Ueda T.
    Anticancer Res; 2005 Jul 15; 25(2A):991-8. PubMed ID: 15868938
    [Abstract] [Full Text] [Related]

  • 60. Darinaparsin inhibits prostate tumor-initiating cells and Du145 xenografts and is an inhibitor of hedgehog signaling.
    Bansal N, Farley NJ, Wu L, Lewis J, Youssoufian H, Bertino JR.
    Mol Cancer Ther; 2015 Jan 15; 14(1):23-30. PubMed ID: 25381261
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.